differences compared with placebo or indicated statin are based on differences ... studies (over 1–2 years) at ezetimibe levels substantially higher than the maximum concentration of a ...

Now an analysis of clinical trials in more than 10,000 patients treated with a fortnightly or monthly injection of a PCSK9 inhibitors suggests they are just as safe as statins and ezetimibe ...

About 71% of patients were receiving moderate-intensity statin monotherapy at baseline. Less than 10% of patients were receiving ezetimibe monotherapy or statin-ezetimibe combination therapy ...

Ezetimibe reduces LDL cholesterol levels, and niacin raises HDL cholesterol levels; however, no previous studies have described the use of these two drugs in combination.

Ezetimibe is used along with a low cholesterol/low fat diet and exercise to help lower cholesterol in the blood. Ezetimibe may be used alone or with other drugs (such as "statins" or fibrates).